Swiss National Science Foundation logo
BRIDGE

BRIDGE Discovery — 10th

Funds high-potential Swiss researchers translating ideas into practical demonstrations to strengthen real-world implementation.

ClosedSwiss National Science FoundationSwitzerland

BRIDGE Discovery is a joint funding programme of the Swiss National Science Foundation (SNSF) and Innosuisse (the Swiss Innovation Agency), designed to close the gap between fundamental research and innovation with tangible social or economic impact. The 10th call for BRIDGE Discovery was launched jointly by Innosuisse and SNSF, with a full proposal submission deadline of 28 April 2026 at 17:00 CE…

Innovation-oriented research projects across all disciplines by experienced researchers, requiring both scientific excellence and a clear vision of social or economic application.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.12–48 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Guides for this application

All guides →
Innosuisse — Swiss Innovation Agency logo
Between cycles

BRIDGE Discovery

🇨🇭Innosuisse · Switzerland

Funds experienced Swiss researchers conducting applied research with high translational potential for industry adoption.

AIBiotech+8
CHF 500K – CHF 2.5M
European Commission logo
Scheduled

AI Predictive Biomarkers for Chronic Diseases

🇪🇺European Commission · European Union

Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.

MedtechBiotech+1
€6M – €8MApr'27
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

🇪🇺European Commission · European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
€8M – €10MApr'27
European Commission logo
Scheduled

Horizon Bio-CCU: Carbon to Products

🇪🇺European Commission · European Union

Funds two €6M projects that use biotechnology to purify captured carbon and turn it into sustainable feedstock for industrial products.

BiotechSynthetic Biology+2
€6MSep'27
EIT RawMaterials logo
Open

EIT RawMaterials KAVA Call 14 — Upscaling

🇪🇺EIT RawMaterials · European Union

Supports research teams and institutions for EIT RawMaterials KAVA Upscaling in materials science, energy systems, and climate technology.

Advanced MaterialsEnergy Tech+3
€500K – €2.5MOct'26
European Commission logo
Scheduled

Industrial Energy: Renewable Heat and Storage

🇪🇺European Commission · European Union

Funds €7–9M projects that replace fossil process energy with renewable heat, electrification and resilient industrial storage.

Energy TechClimate Tech+2
€7M – €9MFeb'27